MarketBeat on MSN
MannKind wins FDA approval for Afrezza in children, opening pediatric diabetes market
MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ...
PD-L1 Expression and Its Prognostic Value in Different Tumor Specimens in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Fifty-two guidelines and consensus statements met ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results